fda warning letter bpc-157 unapproved drug to weigh looser rules on unproven peptides touted by RFK Jr., MAHA FDA issued its first warning

FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link FDA panel narrowly backs unapproved peptide drugs NBC4 Washington FDA's Overreach on Compounded Peptides

SKU: 956081522 · From centoria.fr